Literature DB >> 998804

Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs.

G R Heyndrickx, D H Boettcher, S F Vatner.   

Abstract

A comparison was made of the effects of vasopressin (ADH), methoxamine (MX), and angiotensin II (AN) on coronary and left ventricular dynamics, cardiac output, and regional blood flow distribution in intact, consci9us dogs. At an equal percent pressure elevation, ADH reduced cardiac output and cardiac rate the most, while AN had the least effect. After denervation of arterial baroreceptors, ADH still reduced heart rate, while AN increased it, suggesting nonbaroreceptor negative and positive chronotropic effects, respectively. A differential pattern on peak dP/dt was also observed, with ACH causing a greater reduction than MX while AN did not decrease dP/dt. With heart rate held constant, AN did not reduce dP/dt, suggesting a direct positive inotropic effect since dP/dt should have fallen slightly due to reflex mechanisms, as was observed with MX and ADH. ADH induced the greatest increase in coronary resistance (140%), while the least (46%) was observed with AN, which could be explained, in part, by the differential effects observed on cardiac rate and contractility. The greatest increase in resistance in the iliac bed occurred with ADH (30%), and the least with AN (34%). Conversely, the greatest constriction in the renal bed occurred with AN (95%), and lesser amounts were observed with ADH (36%) and MX (35%). Thus ADH, MX, and AN exert potent yet differential vasoconstricting actions on peripheral beds. In addition, while all three agents elicited coronary vasoconstriction, the differential effects on coronary vascular resistance appeared to be due predominantly to a difference in chronotropic and inotropic actions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998804     DOI: 10.1152/ajplegacy.1976.231.5.1579

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

Review 1.  Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?

Authors:  Pierre Asfar
Journal:  Intensive Care Med       Date:  2003-02       Impact factor: 17.440

2.  Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar.

Authors:  Bart L De Keulenaer; Dianne P Stephens
Journal:  Intensive Care Med       Date:  2003-03-25       Impact factor: 17.440

Review 3.  AKI associated with cardiac surgery.

Authors:  Robert H Thiele; James M Isbell; Mitchell H Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

4.  Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.

Authors:  V Richard; B Ghaleh; A Berdeaux; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.

Authors:  M F Maturi; R Greene; E Speir; C Burrus; L M Dorsey; D R Markle; M Maxwell; W Schmidt; S R Goldstein; R E Patterson
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  [Cardiovascular effect of the antidiuretic hormone arginine vasopressin].

Authors:  W Rascher
Journal:  Klin Wochenschr       Date:  1985-10-01

7.  Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide.

Authors:  A L García-Villalón; J L Garcia; N Fernández; L Monge; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.

Authors:  C S Liang; H Gavras; W B Hood
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 9.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

10.  Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.

Authors:  Andrea Morelli; Monica Rocco; Giorgio Conti; Alessandra Orecchioni; Andrea De Gaetano; Giuliana Cortese; Flaminia Coluzzi; Enrico Vernaglione; Paolo Pelaia; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.